1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Global Gastrointestinal Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Drugs Revenue 2017-2028
1.4.2 Global Gastrointestinal Drugs Sales 2017-2028
1.4.3 Gastrointestinal Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Gastrointestinal Drugs Manufacturing Sites, Area Served, Product Type
2.5 Gastrointestinal Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gastrointestinal Drugs Players Market Share by Revenue
2.5.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Gastrointestinal Drugs Market Facts & Figures by Country
3.3.1 North America Gastrointestinal Drugs Sales by Country
3.3.2 North America Gastrointestinal Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 Europe Gastrointestinal Drugs Sales by Country
3.4.2 Europe Gastrointestinal Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Gastrointestinal Drugs Sales by Region
3.5.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Latin America Gastrointestinal Drugs Sales by Country
3.6.2 Latin America Gastrointestinal Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Gastrointestinal Drugs Sales by Country
3.7.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gastrointestinal Drugs Historic Market Analysis by Type
4.1 Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
4.2 Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Gastrointestinal Drugs Price by Type (2017-2022)
5 Global Gastrointestinal Drugs Historic Market Analysis by Application
5.1 Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
5.2 Global Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Gastrointestinal Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Gastrointestinal Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer Gastrointestinal Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Teva Gastrointestinal Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zeria (Tillotts)
6.6.1 Zeria (Tillotts) Corporation Information
6.6.2 Zeria (Tillotts) Description and Business Overview
6.6.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
6.7.5 Zeria (Tillotts) Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Corporation Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 C.B. Fleet
6.11.1 C.B. Fleet Corporation Information
6.11.2 C.B. Fleet Gastrointestinal Drugs Description and Business Overview
6.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 C.B. Fleet Gastrointestinal Drugs Product Portfolio
6.11.5 C.B. Fleet Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Gastrointestinal Drugs Description and Business Overview
6.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Abbott Gastrointestinal Drugs Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Jiangzhong
6.13.1 Jiangzhong Corporation Information
6.13.2 Jiangzhong Gastrointestinal Drugs Description and Business Overview
6.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Jiangzhong Gastrointestinal Drugs Product Portfolio
6.13.5 Jiangzhong Recent Developments/Updates
6.14 Xian-Janssen
6.14.1 Xian-Janssen Corporation Information
6.14.2 Xian-Janssen Gastrointestinal Drugs Description and Business Overview
6.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio
6.14.5 Xian-Janssen Recent Developments/Updates
7 Gastrointestinal Drugs Manufacturing Cost Analysis
7.1 Gastrointestinal Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gastrointestinal Drugs
7.4 Gastrointestinal Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gastrointestinal Drugs Distributors List
8.3 Gastrointestinal Drugs Customers
9 Gastrointestinal Drugs Market Dynamics
9.1 Gastrointestinal Drugs Industry Trends
9.2 Gastrointestinal Drugs Market Drivers
9.3 Gastrointestinal Drugs Market Challenges
9.4 Gastrointestinal Drugs Market Restraints
10 Global Market Forecast
10.1 Gastrointestinal Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gastrointestinal Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Gastrointestinal Drugs by Type (2023-2028)
10.2 Gastrointestinal Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gastrointestinal Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Gastrointestinal Drugs by Application (2023-2028)
10.3 Gastrointestinal Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gastrointestinal Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Gastrointestinal Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
